Wednesday, September 16, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesGalderma's Restylane Volyme Wins China Temple StudytodayBusiness & M&AEL.En. Profit Surges 45% on Medical Aesthetics Shift2 days agoBusiness & M&AInMode Takeover Bid Expires—Stock Pressure MountstodayMarketGLP-1 Users Driving Body Contouring Surge—Practices Adapt Service Mix2 days agoInjectablesMerz Expands Belotero With Volume and Intense FillerstodayDevices & TechBTL Launches EXOLASE ONE—Fused Erbium Laser Enters Crowded Market2 days agoDevices & TechInMode Launches Morpheus8 Cool on Morpheus8MAXtodayDevices & TechInMode Adds Cooling to Morpheus8MAX—RF Microneedling Gets Comfort Edge2 days agoInjectablesMerz Gets FDA Nod for BELOTERO VOLUME and INTENSEyesterdayBusiness & M&AEL.En. Medical Segment Drives 9% Revenue GrowthyesterdayDevices & TechECHOLASER X4 Clears FDA 510(k) for General SurgeryyesterdayBusiness & M&AGalderma's Launch Spend Paying Off as Margins Widenyesterday
Devices & Tech

SkinStylus Gets FDA Nod for Periorbital Wrinkles

RF microneedling device expands cleared indications to include eye-area treatment across all skin types.

Image: Inside MedSpa

SkinStylus has received FDA clearance for the improvement of periorbital wrinkles across all skin types, adding a new indication to its radiofrequency microneedling platform. The clearance expands the device's addressable market into a high-demand anatomical zone where practices already perform filler and neuromodulator work.

The periorbital region has historically been challenging for RF microneedling due to proximity to the eye and variable skin thickness, making this clearance clinically and commercially significant. The all-skin-type language removes the need for separate protocols by Fitzpatrick classification, simplifying patient selection and treatment planning.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

RF microneedling now cleared for periorbital wrinkles across all skin types.

For practices already running SkinStylus, this is a straightforward revenue add—the device footprint is already there, and periorbital work pairs naturally with existing toxin and filler revenue. The indication also positions the device against fractional CO2 and erbium lasers in the fine-line space, where downtime and post-inflammatory hyperpigmentation remain concerns.

Source: original report ↗

Frequently asked questions

Can SkinStylus treat under-eye wrinkles safely?

Yes. SkinStylus has received FDA clearance for periorbital wrinkles across all skin types, including the sensitive eye area. The clearance addresses the historical challenge of proximity to the eye and variable skin thickness in that region.

Does SkinStylus work on all skin types for eye wrinkles?

Yes. The FDA clearance includes all-skin-type language, meaning practices no longer need separate treatment protocols based on Fitzpatrick classification for periorbital treatment.

How does RF microneedling compare to CO2 laser for eye wrinkles?

RF microneedling like SkinStylus offers advantages over fractional CO2 and erbium lasers in the periorbital zone, particularly reduced downtime and lower risk of post-inflammatory hyperpigmentation—critical concerns in the delicate eye area.

Is periorbital wrinkle treatment a good add-on service for existing SkinStylus practices?

Yes. Since practices already have the device footprint in place, periorbital treatment is a straightforward revenue addition that pairs naturally with existing toxin and filler services in the eye area.

What makes the periorbital indication clinically significant for RF microneedling?

The periorbital region has historically been challenging for RF microneedling due to eye proximity and variable skin thickness. This FDA clearance validates that SkinStylus can safely and effectively address these anatomical complexities.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/skinstylus-fda-periorbital-wrinkles/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Get the free brief Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Get the free brief